Olympia Pharmaceuticals Purchases 55,000 Sq Ft Facility in Florida
October 29, 2024 09:00 ET | Olympia Pharmaceuticals
ORLANDO, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA 503B pharmaceutical outsourcing facility and 503A pharmacy, today announced it has purchased a...
cmi_logo.png
[Latest] Global Pharmacy Management System Market Size/Share Worth USD 156.6 Billion by 2032 at a 10.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 27, 2023 23:30 ET | Custom Market Insights
Austin, TX, USA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmacy Management System Market Size, Trends and Insights By Solution Type...
ARC logo.png
Plastic Compounding Market Value Predicted To Reach US$ 95,425.3 Million By 2026 Covering Covid-19 Impact: Acumen Research and Consulting
June 29, 2021 10:35 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Plastic Compounding Market– Global Industry Analysis, Market Size, Opportunities...
New CAPS Logo.jpg
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
December 04, 2018 10:57 ET | CAPS, a B. Braun Medical Inc. company
IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS), a B. Braun company and the nation’s largest network of outsourcing admixture pharmacies, has today...
Earth Science Tech,
Earth Science Tech, Inc. Shares Achievements & Updates on it’s Cannabis CBD-Based Nutraceutical Patent Compounding
May 02, 2017 07:45 ET | Earth Science Tech, Inc.
Hollywood, May 02, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and...
Standards for Compounding Sterile Preparations Go Under Major Revision
September 28, 2015 16:14 ET | United States Pharmacopeia
General Chapter <797> is pre-posted for public comment   ROCKVILLE , MD., Sept. 28, 2015 (GLOBE NEWSWIRE) -- The U.S. Pharmacopeial Convention (USP) pre-posted General Chapter 797...
BioCorRx, Inc. Final
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
July 07, 2015 08:00 ET | BioCorRx
Los Angeles, July 7, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program® used for the treatment of alcohol and opioid dependence, announces the finalization of...
BioCorRx, Inc. Annou
BioCorRx, Inc. Announces Reinstatement of Letter of Understanding to Acquire Naltrexone Implant Formula for Treating Addiction
March 18, 2015 08:00 ET | BioCorRx
Los Angeles, March 18, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program® used for the treatment of alcohol and opioid dependence, announces the reinstatement...
digiMedical Solutions, Inc. Signs Contract to Implement .Net-Based Digital Prescription Software and Call Center Services for Dr. Geoffrey Colino
July 02, 2008 09:47 ET | digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - July 2, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr. Geoffrey Colino in Bonita Springs,...
digiMedical Solutions, Inc. Signs Letter of Intent With Guardian Health Systems in Support of $10 Million 2008 Revenue Goal
May 15, 2008 12:45 ET | digiMedical Solutions, Inc.
DALLAS, TX--(Marketwire - May 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced the Company has signed a non-binding letter of intent (LOI) with Guardian Health Systems. The...